Estela Rutiaga
Family Medicine · Marana, AZNPI 1083876064
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $549 and has fallen 96.7% since, to $18 in 2024.
Across 76 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$221
- Boehringer Ingelheim$205
- Novo Nordisk$121
- Amgen$118
- Pfizer$112
- Novartis$102
- plus $447 from 17 others
What the payments were for
- Food & beverage$1,326100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $221 |
| Boehringer Ingelheim | 11 | $205 |
| Novo Nordisk | 8 | $121 |
| Amgen | 5 | $118 |
| Pfizer | 8 | $112 |
| Novartis | 5 | $102 |
| Abbott | 4 | $82 |
| Lilly USA, LLC | 4 | $61 |
| AstraZeneca | 3 | $42 |
| Dexcom, Inc. | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Phadia US Inc. | 2 | $25 |
| Sanofi Pasteur Inc. | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Dynavax Technologies Corporation | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Exact Sciences | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $12 |
How this compares
$1,326 in reported general payments places this provider in the 75th percentile of 2,099 family medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 17 | $23,238 |
| EliquisApixaban | 19 | $20,823 |
| JardianceEmpagliflozin | 13 | $18,111 |
| TrulicityDulaglutide | 13 | $12,269 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $4,173 |
| Atorvastatin Calcium | 157 | $1,458 |
| Levothyroxine Sodium | 122 | $1,057 |
| Gabapentin | 44 | $1,055 |
| Losartan Potassium | 68 | $894 |
| Omeprazole | 54 | $825 |
| Pregabalin | 18 | $802 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $617 |
| Rosuvastatin Calcium | 52 | $543 |
| Amlodipine Besylate | 83 | $516 |
| Simvastatin | 59 | $504 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $121 | $23,23817 claims |
| PfizerEliquis | $112 | $20,82319 claims |
| Boehringer IngelheimJardiance | $205 | $18,11113 claims |
| Lilly USA, LLCTrulicity | $61 | $12,26913 claims |
| AstraZenecaSymbicort | $42 | $4,17316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Marana
- Douglas CunninghamPhoenix$1.8M
- Mitchell EdelsteinPhoenix$741K
- Lorena Jauregui-CovarrubiasYuma$491K
- Sam FereidouniScottsdale$486K
- Jessica BlancoChandler$447K
- Heather ElwoodPhoenix$236K
- Ryan CaseyYuma$231K
- Suzanne BentzMesa$174K
- Brent AllanParadise Valley$108K
- Ahmed AghaPhoenix$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.